Osimertinib is a drug that targets the T790M mutation in EGFR for people with Non-Small Cell Lung Cancer. It goes after particular changes in the EGFR. You can get this drug in two doses: 40 mg and 80 mg, both in coated tablets.
The doc usually says to take 80 mg of this stuff once a day, whether you eat or not. Each bottle comes with 30 tablets. It stops a protein called EGFR from doing its thing, which helps cancer cells grow and spread.
It’s mostly for folks who’ve been on other EGFR drugs and then their cancer got wise to them because of this T790M thing. Patients really need to do what their healthcare provider tells them, like sticking to the right dose and any checks they need to do.
